Transcriptomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Transcriptomics Market is segmented by Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), and Sequencing Technologies), Product (Consumables, Instrument, and Other Products), Application (Diagnostics and Disease Profiling, Drug Discovery, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Transcriptomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Transcriptomics Industry Overview

The transcriptomics market is slightly fragmented due to many companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some of the key players in the market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., GE Healthcare, Merck KGaA, 10x Genomics, Agilent Technologies Inc., BGI Genomics, Dovetail Genomics, Fluidigm Corporation, Illumina Inc., Natera Inc., PerkinElmer Inc., Promega Corporation, and Qiagen NV among others.

Transcriptomics Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Thermo Fisher Scientific

  3. Merck KGaA

  4. GE Healthcare

  5. Bio-Rad Laboratories

  6. *Disclaimer: Major Players sorted in no particular order
Picture2.png